Director/PDMR Shareholding

RNS Number : 6671P
Burberry Group PLC
30 May 2018
 

Burberry Group plc (the "Company") - Director/PDMR Shareholding

 

The Company announces that it received notification on 29 May 2018 that Marco Gobbetti, Chief Executive Officer and a director of the Company, purchased 60,000 Ordinary Shares of 0.05 pence each in the Company ("Shares") on 29 May 2018 at a price of 2001.85 pence per Share.

 

 

30 May 2018

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Marco Gobbetti

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

213800PE1KEFCNFR1R50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each

 

 

GB0031743007

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£20.0185

 

60,000

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

£20.0185

 

60,000

£1,201,110

e)

Date of the transaction

2018-05-29

 

f)

Place of the transaction

XLON





 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFETEEIIVIT
UK 100